Olgram
PrivateLast Round
Grant
Jun 7, 2024
Total Funding Raised
$6.79M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Olgram operates in Healthcare & Life Sciences and is based in France. Its latest recorded funding round was a Grant round in June 2024.
Olgram is a biotechnology company that develops marine-derived molecules to treat immune deficiencies and chronic bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Olgram Comparables
Compare Olgram with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ingineeon GmbH | 78% | |
| Affirma Biotech | 78% | |
| MetrioPharm AG | 75% |
For institutional investors. Book with your work email.
Olgram Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 7, 2024 | ||||
| Seed | Mar 31, 2021 | ||||
| Pre Seed | Mar 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Olgram Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Region Bretagne | Seed |
| Bpifrance | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Open roles tripled to 3, representing 50% of headcount.
- Jun 7, 2024
$2.8M grant received from Bpifrance.
For institutional investors. Book with your work email.
Olgram Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Olgram's valuation, stock price, and market status.
Is Olgram a public or private company?
Olgram is a private company.
What is the current stock price of Olgram?
Olgram is a private company, so its shares have no public market price. Caplight tracks Olgram's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Olgram worth (valuation)?
Valuation information for Olgram is not publicly available.
Can I buy Olgram stock?
Olgram shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Olgram's last funding round?
Olgram's most recent funding round was Grant on June 7, 2024.
Who are the main investors in Olgram?
Key investors in Olgram include Region Bretagne, Bpifrance.
Will Olgram IPO soon?
No public IPO plans have been announced for Olgram.
How can I track Olgram secondary market activity?
Caplight tracks bids, offers, and trades in Olgram's shares on secondary markets.